I. Magrí

Predicting Response to Chemotherapy With Early-Stage Lung Cancer

Bartomeu Massuti, Rafael Rosell, R. Rosell, 2011, Cancer journal.

KRAS mutations in lung cancer.

Carlota Costa, Rafael Rosell, Miguel Angel Molina-Vila, 2013, Clinical lung cancer.

mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients

R. Rosell, M. Taron, M. Santarpia, 2011, Journal of Translational Medicine.

Tyrosine kinase inhibitors for non-small-cell lung cancer: finding patients who will be responsive

G. Altavilla, R. Rosell, M. Santarpia, 2011, Expert review of respiratory medicine.

Tyrosine kinase inhibitors for non-small-cell lung cancer: finding patients who will be

G. Altavilla, R. Rosell, I. Magrí, 2011 .

Efficacy and Safety of Nivolumab in Previously Treated Patients With Non-Small-cell Lung Cancer: Real World Experience in Argentina.

M. Rizzo, G. Recondo, R. Kowalyszyn, 2020, Clinical lung cancer.

Predicting Response to Chemotherapy With Early-Stage Lung Cancer

R. Rosell, M. Taron, M. Santarpia, 2011, Cancer journal.